Finance News Archive

Arena Pharmaceuticals Inc. reported a net loss of $32.1 million, or 15 cents per share, for the quarter ended Dec. 31, and a net loss of $60.5 million, or 28 cents per share, for the year ended Dec. 31, and Halozyme Therapeutics Inc. showed a net loss of $68.4 million, or 56 cents per share, for the year ended Dec. 31, and a net loss of $5.3 million, or 4 cents per share, for the fourth quarter, according to company announcements, SEC filings and Bloomberg News.

What a difference a month makes. Remember the sharp decline in stock prices in January when the major indexes started the year with a decline of about 3.5 percent? Well, the bulls were back in February with the Dow industrials gaining 5.6 percent and the S&P 500 up 5.5 percent, its best month since October 2011.

Major Economic Releases

Trustees at a San Diego pension fund who quarreled over investment strategy now are trading allegations about guns, bullying, and racial and sexual harassment, threatening the search for an investment chief.

Business and professional groups will offer a range of activities this week.

Unmanned aerial vehicle maker 3D Robotics, whose engineering is based in San Diego and manufacturing in Tijuana, announced it secured its third round of venture financing -- a $50 million Series C led by Qualcomm Inc.

"We're the tax collectors and we're here to help," State Board of Equalization member Diane Harkey told members of the North San Diego Business Chamber on Friday, saying that she and other members of the board are trying to streamline auditing procedures and alert businesses to exemptions that they might be qualified for.

The San Diego Stock Exchange Index closed lower Friday at 192.89, down 0.73 percent from Thursday. Declining issues beat decliners 57 to 44, and 81 issues were unchanged. Isis Pharmaceuticals Inc. (Nasdaq: ISIS) was the top dollar gainer, up $1.23 to $68.56. Auspex Pharmaceuticals Inc. (Nasdaq: ASPX) was the top dollar loser, down $3.07 to $67.24. For the complete, updated San Diego Stock Exchange Index visit sddt.com/stocks.

A proposal released last week by President Barack Obama takes aim at the fees charged on a variety of retirement plans and the way services are provided to millions of retirement-oriented investors.

Over the years clients have asked whether I'm going to buy this or that IPO, or the latest and greatest IPO that is being released.

San Diego-based Tandem Diabetes Care Inc. (Nasdaq: TNDM), a medical device company and manufacturer of the t:slim and t:flex insulin pumps, announced the pricing of an underwritten public offering of 5.25 million shares of its common stock at $11.50 per share.

Putting the wraps on February. Hard to believe, huh? The first two months of 2015 are just about behind us and it truly has been a tale of two months.

Major Economic Releases

Small-business owners throughout the West Coast are the most optimistic they have been in four years, with a record-breaking 90 percent believing their businesses are headed in the right direction, according to an annual survey of small businesses conducted by Union Bank.

The San Diego Stock Exchange Index closed higher Thursday at 194.30, up 0.21 percent from Wednesday. Advancing issues beat decliners 51 to 43, and 88 issues were unchanged. Receptos Inc. (Nasdaq: RCPT) was the top dollar gainer, up $4.18 to $126.51. Dexcom Inc. (Nasdaq: DXCM) was the top dollar loser, down $1.38 to $61.96. For the complete, updated San Diego Stock Exchange Index, visit sddt.com/stocks.

Global stocks were mostly higher Thursday on upbeat corporate earnings and rising Chinese factory output after the chairwoman of the U.S. Federal Reserve said it will be patient about increasing interest rates.

Cytori Therapeutics Inc. announced that it received FDA approval to expand the number of Scleroderma clinical trial sites to 20 from 12 centers in the United States, and Illumina Inc. announced its new Illumina Accelerator Boost Capital has secured an initial capital commitment of $40 million from Viking Global Investors, a privately owned, global investment firm, according to company announcements, SEC filings and Bloomberg News.

Sempra Energy (NYSE: SRE) reported 2014 earnings of $1.16 billion, or $4.63 per share, and fourth-quarter earnings of $297 million, or $1.18 per share.

Another record on Wall Street. Sure, it wasn't much but the 15-point gain yesterday in the Dow industrials was enough to take the blue chip index to its third record close in the past four sessions.

Major Economic Releases